The latest ASX 200 stocks downgraded by top brokers

The market looks set to end the week on a negative note, but some ASX stocks are feeling more heat after being downgraded by leading brokers.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market looks set to end the week on a negative note, but some ASX stocks are feeling more heat after being downgraded by leading brokers.

The S&P/ASX 200 Index (Index:^AXJO) shed 0.7% of its value to trade just under the psychologically important 6,000 mark.

However, the top 200 benchmark is still finish the week with a more than 1% gain, although the same can't be said for the RESMED/IDR UNRESTR (ASX: RMD) share price.

ResMed's double downgrad

Shares in the sleep disorder treatment company tumbled 3.1% to $25.08 in after lunch trade. This makes it the third worst performer on the ASX 200 after the JANUS/IDR UNRESTR (ASX: JHG) share price and V MONEY UK/IDR UNRESTR (ASX: VUK) share price.

ResMed is losing favour today as not one, but two brokers downgraded their recommendation on the stock following its profit results.

While ResMed's earnings came in ahead of consensus, the good news is reflected in its share price, according to Morgan Stanley.

Earnings beat fails to excite

The company's earnings beat is largely driven by better-than-expected cost control and demand for ventilators to treat severe COVID-19 cases.

These tailwinds are likely to fade with the broker pointing to an acceleration in cost growth as the economy picks up speed. Further, demand for ventilators will also taper off in FY21.

The fall-off in ventilator sales will need to be made up by rising demand for its core sleep apnea solutions.

Slower recovery for core business

"The main challenge now is to weigh up what looks likely to be a sharp tapering of ventilator demand (10-15% of Group) against a steady recovery in sleep apnea (85-90%) through the coming quarters, which is clearly subject to a wide degree of uncertainty," said Goldman Sachs.

The fact is the pace of growth for its core products is unlikely to make up for falling ventilator sales.

Morgan Stanley cut its recommendation to "equal-weight" from "overweight" with a price target of $25.40 a share.

Goldman lowered its rating on ResMed to "neutral" from "buy" with a target price of $26.40 a share.

Hanging up on TPG

Another stock that's underperforming today is the TPG Telecom Ltd (ASX: TPG) share price, which got downgraded by UBS to "sell" from "neutral".

The broker believes that the special dividend of $0.49 a share and the Tuas Ltd (AS: TUA) spin-off haven't been unwound from the current share price.

"On the day prior to the announcement of the special dividend, TPG was trading at $8.05, and rallied to $8.90 immediately prior to the completion of the merger," said UBS.

"This compares with our previous $8.00 valuation. Our new valuation is $7.20, which removes the special dividend and Tuas."

Too big a premium to Telstra

Further, UBS pointed out that TPG trades at a premium to the Telstra Corporation Ltd (ASX: TLS) share price.

While some premium may be justified due to synergies from TPG's merger with Vodafone, UBS thinks it's currently too excessive.

Motley Fool contributor Brendon Lau owns shares of Telstra Limited and TPG Telecom Ltd. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Evolution Mining, G8 Education, Lottery Corp, and Lynas shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

Two men in hard hats and high visibility jackets look together at a laptop screen at a mine site.
Gold

Down 50% in a year, time to pounce on this beaten-down ASX 200 gold stock?

A leading expert offers his verdict on this beaten-down ASX 200 gold miner.

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why CBA, G8 Education, JB Hi-Fi, and Vault Minerals shares are falling today

These shares are falling on Thursday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

These were the worst ASX 200 shares to buy in June

These shares took a tumble last month. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Domino's, Helia, Qantas, and Zip shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »

A sad man looks at his computer screen as he holds a slice of pizza in his hand with an open pizza box in front of him on his desk.
Share Fallers

Why did the Domino's share price just crash 17%?

ASX investors just sent Domino’s shares tumbling more than 17% today. But why?

Read more »

Red arrow going down with share prices in red symbolising a falling share price
Share Fallers

These 5 ASX All Ords shares were the biggest fallers of FY25

These are the ASX All Ords stocks you didn't want to own in FY25...

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why CBA, HMC Capital, Mineral Resources, and NIB shares are falling today

These shares are falling on Tuesday. But why?

Read more »